貴州輪胎(000589.SZ):國內工廠目前剩餘兩期項目用地,越南工廠還有第三期規劃,項目尚未確定
格隆匯7月19日丨貴州輪胎(000589.SZ)公佈於2023年7月18日接受特定對象調研,就“請介紹公司目前的產能情況?未來又有怎樣的規劃?”
公司回覆稱,公司聚焦商用輪胎領域,目前具備900多萬條的設計產能。公司當前正積極推進的項目主要有兩個:一是國內“年產38萬套全鋼工程子午線輪胎智能製造項目”;二是越南“年產95萬條高性能全鋼子午線輪胎項目”。國內工廠目前剩餘兩期項目用地,越南工廠還有第三期規劃,項目尚未確定。未來,公司將積極、審慎規劃後續新項目,持續推動國內貴陽和越南前江雙基地良性發展,不斷擴大經營規模,實現高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.